This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Insulet Corp (PODD)

NASDAQ: Health Care

$46.05 +0.57 | 1.30%
11/26/14 - 11:32 AM ET (BATS BZX Real-time Price)
  • Prev Close: 45.48
  • Day's Open: 45.63
  • Volume: 34.89K
  • Avg Vol: 506.60K
  • Shares Outstanding: 56.08M
  • Mkt Cap: 2.57B
  • Div: --
  • Div Yield: --
  • P/E: N/A
  • EPS: -0.83
PODD Day's Range
$45.6175
$46.04
PODD 52 Week Range
$30.04
$51.31
PODD Business Summary
Insulet Corporation develops, manufactures, and sells insulin infusion systems for people with insulin-dependent diabetes in the United States.View PODD key stats
PODD Performance as of Prev. Close
YTD
22.59%
3-Mo
29.28%
1-Yr
27.11%
3-Yr
161.98%
PODD EPS Performance
1-Yr Ago
-0.83
2-Yrs Ago
-1.08
3-Yrs Ago
-1.22
PODD Percentage in these ETFs
0.040%
0.013%
0.011%
0.004%
0.002%
PODD News

Analysts Ratings for PODD

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 10 9 9 9
Moderate Buy 1 1 1 1
Hold 2 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
GET PODD ANALYST REPORT

Brokerage Partners

PODD Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs